MITO-DIRECTED CONJUGATED ESTROGENIC COMPOUND AND ITS METHOD OF OBTAINING

MX434466BActive Publication Date: 2026-05-19UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO (UNAM) +1

0 Cites 0 Cited by

Patent Information

Application Number: MX2023006190
Authority / Receiving Office: MX · MX
Patent Type: Patents
Current Assignee / Owner
Filing Date: 2023-05-25
Publication Date: 2026-05-19
Estimated Expiration: 2043-05-25

Application Information

Patent Timeline

25 May 2023

Application

MX2023006190

19 May 2026

Publication

MX434466B

IPC: A61P25/28; A61K9/00; A61K9/48; A61K31/57; A61K31/565; A61P3/10; A61P25/16

CPC: A61P25/28; A61K9/0019; A61K9/48; A61K31/57; A61K31/565; A61P3/10; A61P25/16

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Abstract

The present invention relates to mito-directed conjugated estrogenic compounds and more specifically to novel mito-directed estrogenic derivatives of general formula (I), which specifically activate mitochondrial estrogen receptors (mtERs), and overcome the mitoprotective effects caused by the administration of conventional estrogenic compounds, without causing adverse effects on cells.

Need to check novelty before this filing date? Find Prior Art